Acino's IPO

Acino raised a round of funding on , . Investors include Public.

Acino, a Swiss-based pharmaceutical company, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino specializes in advanced d…

Articles about Acino's IPO: